EMA validates Bristol Myers Squibb’s application for Opdivo plus Yervoy for first-line treatment of adult patients with microsatellite: Princeton, New Jersey Wednesday, May 8, 2 ...
MPA urges AP govt to clarify the authority to inspect Ayurveda retail shops as per DMR Act: Peethaambaran Kunnathoor, Chennai Wednesday, May 8, 2024, 08:00 Hrs [IST] The Medical P ...
Department of Pharmaceuticals (DoP) secretary Dr Arunish Chawla has emphasised on the importance of policymakers and industry working together to come up with a sturdy policy stack for growth of the ...
Liposomal technology revolutionises pharma and nutraceutical industries in India: Nandita Vijayasimha, Bengaluru Wednesday, May 8, 2024, 08:00 Hrs [IST] Indian pharma & nutraceuti ...
The Indian Council of Medical Research (ICMR) has announced an invitation for Expression of Interest (EoI) from experienced Indian agencies for the transfer of technology related to the "Human ...
To bring the Indian pharmaceutical quality standards on par with the international quality standards, the Union Health Ministry on December 28, 2023 notified the Revised Schedule M for which the ...
RedHill Biopharma’s opaganib as a therapy for Ebola virus receives Chinese patent: Tel-Aviv, Israel Tuesday, May 7, 2024, 15:00 Hrs [IST] RedHill Biopharma Ltd., a specialty bio ...
IIHMR University has 200 healthcare start-ups from across India to come under its Saamarthya 2.O ...
Mediar begins patient dosing in US FDA approved phase 1 trial of MTX-463: Boston Tuesday, May 7, 2024, 16:00 Hrs [IST] Mediar Therapeutics, Inc., a biotechnology company advancing ...
Naprod Life Sciences successfully renews EU-GMP certification for its Palghar facility: Our Bureau, Mumbai Tuesday, May 7, 2024, 16:30 Hrs [IST] Naprod Life Sciences has announced ...